HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2006-0540v1 25/5/1126    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hedlund, E. Articles by Kim, K.-S. Search for Related Content PubMed PubMed Citation Articles by Hedlund, E. Articles by Kim, K.-S.

EMBRYONIC STEM CELLS

Selection of Embryonic Stem Cell-Derived Enhanced Green Fluorescent Protein-Positive Dopamine Neurons Using the Tyrosine Hydroxylase Promoter Is Confounded by Reporter Gene Expression in Immature Cell Populations

^aUdall Parkinson's Disease Research Center for Excellence,
^bMolecular Neurobiology Laboratories, and
^cNeuroregeneration Laboratories, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA

Key Words. Genetic engineering • Fluorescence-activated cell sorting • Parkinson disease Stage-specific embryonic antigen 1 • CD-15

Correspondence: Kwang-Soo Kim, Ph.D., McLean Hospital/Harvard Medical School, Molecular Neurobiology Laboratory, 115 Mill Street, Belmont, Massachusetts 02478, USA. Telephone: 617-855-2024; Fax: 617-855-3479; e-mail: kskim{at}mclean.harvard.edu; Ole Isacson, Ph.D., McLean Hospital/Harvard Medical School, Neuroregeneration Laboratory, 115 Mill Street, Belmont, Massachusetts 02478, USA. Telephone: 617-855-3283; Fax: 617-855-3284; e-mail: isacson{at}hms.harvard.edu

Received August 29, 2006; accepted for publication January 9, 2007.
First published online in STEM CELLS EXPRESS   January 18, 2007.



Transplantation of mouse embryonic stem (mES) cells can restore function in Parkinson disease models, but can generate teratomas. Purification of dopamine neurons derived from embryonic stem cells by fluorescence-activated cell sorting (FACS) could provide a functional cell population for transplantation while eliminating the risk of teratoma formation. Here we used the tyrosine hydroxylase (TH) promoter to drive enhanced green fluorescent protein (eGFP) expression in mES cells. First, we evaluated 2.5-kilobase (kb) and 9-kb TH promoter fragments and showed that clones generated using the 9-kb fragment produced significantly more eGFP+/TH+ neurons. We selected the 9-kb TH clone with the highest eGFP/TH overlap for further differentiation, FACS, and transplantation experiments. Grafts contained large numbers of eGFP+ dopamine neurons of an appropriate phenotype. However, there were also numerous eGFP+ cells that did not express TH and did not have a neuronal morphology. In addition, we found cells in the grafts representing all three germ layers. Based on these findings, we examined the expression of stem cell markers in our eGFP+ population. We found that a majority of eGFP+ cells were stage-specific embryonic antigen-positive (SSEA-1+) and that the genetically engineered clones contained more SSEA-1+ cells after differentiation than the original D3 mES cells. By negative selection of SSEA-1, we could isolate a neuronal eGFP+ population of high purity. These results illustrate the complexity of using genetic selection to purify mES cell-derived dopamine neurons and provide a comprehensive analysis of cell selection strategies based on tyrosine hydroxylase expression.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				E. Hedlund, J. Pruszak, T. Lardaro, W. Ludwig, A. Vinuela, K.-S. Kim, and O. Isacson Embryonic Stem Cell-Derived Pitx3-Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence-Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease Stem Cells, June 1, 2008; 26(6): 1526 - 1536. [Abstract] [Full Text] [PDF]

				M. Wernig, J.-P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson, and R. Jaenisch Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease PNAS, April 15, 2008; 105(15): 5856 - 5861. [Abstract] [Full Text] [PDF]

				J. Pruszak, K.-C. Sonntag, M. H. Aung, R. Sanchez-Pernaute, and O. Isacson Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations Stem Cells, September 1, 2007; 25(9): 2257 - 2268. [Abstract] [Full Text] [PDF]